Sarat Sunthornyothin
Chulalongkorn University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sarat Sunthornyothin.
Archives of Gynecology and Obstetrics | 2009
Lalita Wattanachanya; Udomsak Bunworasate; Wanee Plengpanich; Natnicha Houngngam; Patinut Buranasupkajorn; Sarat Sunthornyothin; Vorasuk Shotelersuk; Thiti Snabboon
BackgroundPheochromocytoma manifesting during pregnancy is uncommon but it is responsible for a high maternal and fetal mortality rate, especially when unrecognized. Most cases of pheochromocytoma are sporadic but they can be part of hereditary autosomal dominant syndromes.CaseWe describe a case of bilateral pheochromocytoma in a term-pregnant patient with a previous history of medullary thyroid carcinoma (MTC). Her genetic study revealed a heterozygous mutation, c.1900T>C, in the RET proto-oncogene which confirmed the diagnosis of multiple endocrine neoplasia type 2A (MEN2A). Unrecognized, the tumors caused a crisis with fatal outcome in the mother during the postpartum period. This event might have been prevented if the tumor had been detected previously.ConclusionMEN2A affected pregnancy is an unusual condition. This syndrome should be suspected when a pregnant patient has a history of MTC. Early detection and appropriate management can prevent serious maternal and fetal complications. We also reviewed the literature of MEN2A-affected pregnancies.
Journal of Endocrinological Investigation | 2007
Thiti Snabboon; Wanee Plengpanich; S. Saengpanich; S. Sirisalipoch; S. Keelawat; Sarat Sunthornyothin; Weerapan Khovidhunkit; S. Suwanwalaikorn; Vitaya Sridama; Vorasuk Shotelersuk
Pendred syndrome is an autosomal recessive disorder characterized by congenital sensorineural deafness, goiter, and impaired iodide organification. It is caused by mutations in the PDS gene. Most published mutation studies of Pendred syndrome have dealt with Western populations. In this study, we examined clinical and molecular characteristics of 16 affected individuals in 6 unrelated Thai families. Of all the affected, 100% (16/16) had bilateral deafness, 68.8% (11/16) goiters, and 25% (4/16) hypothyroidism. Follicular thyroid carcinoma and Hürthle cell adenoma were found in affected members of a family, raising the possibility of an increased risk of thyroid carcinoma in Pendred syndrome patients. Sequence analysis of the entire coding region of the PDS gene successfully identified all 12 mutant alleles in these 6 families. The 12 identified mutant alleles constituted 6 distinct mutations including 3 splice site mutations (IVS4-1G>A, IVS7-2A>G, IVS9-1G>A), one frame shift mutation (1548insC) and 2 missense mutations (T67S, H723R). Eight mutations out of 12 were constituted by IVS7-2A>G and 1548insC, each one being present in 4 distinct alleles in our studied group. The identification of these two frequent PDS mutations will facilitate the molecular diagnosis of Pendred syndrome in Thai populations. In addition, three newly identified mutations, T67S, IVS4-1G>A, and IVS9-1G>A, were not observed in 50 unrelated healthy Thai controls.
Diabetes Research and Clinical Practice | 2010
Yotsapon Thewjitcharoen; Sarat Sunthornyothin
A retrospective review was conducted of medical records of newly diagnosed diabetes in adults who presented with DKA between 2003 and 2007. The majority of DKA in Thailand could not be classified as classical type 1 diabetes. Some newly diagnosed people presenting with DKA could be safely withdrawn from insulin treatment.
Journal of the Endocrine Society | 2018
Wasita Warachit; Taywin Atikankul; Natnicha Houngngam; Sarat Sunthornyothin
Abstract Somatic KCNJ5 mutations result in excess aldosterone production and are reported to be more common in Asia than elsewhere. To assess the prevalence of somatic KCNJ5 mutations in Thai patients with aldosterone-producing adrenal adenomas (APAs) in a single tertiary center, we analyzed the paraffin-embedded tissue of KCNJ5 mutations from 96 patients with sporadic APAs who underwent unilateral laparoscopic adrenalectomy at our center during 2007 to 2016. We also assessed the clinical characteristics, treatment outcomes, and biochemistry and histologic differences among patients with and without somatic KCNJ5 mutations. Of the 96 patients with APA, 67 (70%) had somatic mutations of the KCNJ5 gene: 39 patients with p.G151R, 26 patients with p.L168R, one patient with p.T158A, and one patient with p.W126R. All patients presented with hypertension. Hypokalemia was documented in 98% of patients. The hypertension cure rate at 1 year after surgery was 35%. Patients with somatic KCNJ5 mutations required more potassium supplementation and had adrenal histology compatible with zona fasciculata–like cells compared with patients without the mutations (all P < 0.05). There were no significant differences in preoperative plasma aldosterone concentration (PAC), plasma renin activity, aldosterone/renin ratio, potassium level, treatment of hypertension, tumor size, and hypertension cure rate among patients in the KCNJ5-mutant and nonmutant groups. In a multivariate analysis, a higher PAC was associated with the presence of somatic KCNJ5 mutations. In summary, the prevalence of somatic KCNJ5 mutations in patients with sporadic APAs in Thailand, an Asian country with residents of different ethnic backgrounds, is comparable to previous reports in Asia.
Urology | 2013
Yotsapon Thewjitcharoen; Taywin Atikankul; Sarat Sunthornyothin
The coexistence of pheochromocytoma and renal artery stenosis had been reported occasionally from the possible mechanism of catecholoamine-induced vasospasm and extrinsic compression of renal artery in some reported cases. However, renal infarction caused by pheochromocytoma is an uncommon phenomenon. Herein, we report an interesting case of adrenal pheochromocytoma associated with renal artery thrombosis, which should be included in the differential diagnosis of pheochromocytoma patients who present with abdominal pain.
Annals of Internal Medicine | 2004
Weerapan Khovidhunkit; Sarat Sunthornyothin
Internal Medicine | 2014
Yotsapon Thewjitcharoen; Shanop Shuangshoti; Sukalaya Lerdlum; Rungsak Siwanuwatn; Sarat Sunthornyothin
Endocrine | 2010
Thiti Snabboon; Wanee Plengpanich; Natnicha Houngngam; Patinut Buranasupkajorn; Nattachet Plengvidhya; Wisan Sereepapong; Sarat Sunthornyothin; Vorasuk Shotelersuk
Southeast Asian Journal of Tropical Medicine and Public Health | 2006
Thiti Snabboon; Wanee Plengpanich; Vitaya Sridama; Sarat Sunthornyothin; Sompongse Suwanwalaikorn; Weerapan Khovidhunkit
Internal Medicine | 2010
Promphan Pruksakorn; Shanop Shuangshoti; Rungsak Siwanuwatn; Sukalaya Lerdlum; Sarat Sunthornyothin; Thiti Snabboon